GSK plc reports

Company location
London
GSK plc has filed 6,794 SEC EDGAR filings since 12 Jan 2001

SEC filing history

Showing 801-825 of 1,000 matching filings.

Per page
25
Current page
33
SC 13D/A

AMENDMENT TO FORM SC 13D

Filing date
16 May 2023
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
15 May 2023
Reporting date
15 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

BLOCK LISTING INTERIM REVIEW

Filing date
15 May 2023
Reporting date
15 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
12 May 2023
Reporting date
12 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

MENABCWY VACCINE PRELIMINARY PHASE III RESULTS

Filing date
12 May 2023
Reporting date
12 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

STATEMENT: ZANTAC LITIGATION UPDATE BC CANADA

Filing date
12 May 2023
Reporting date
12 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

GSK COMPLETES SALE OF SHARES IN HALEON PLC

Filing date
12 May 2023
Reporting date
12 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

CURRENT REPORT OF FOREIGN ISSUER

Filing date
12 May 2023
Reporting date
11 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
09 May 2023
Reporting date
09 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
04 May 2023
Reporting date
04 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

RESULT OF AGM

Filing date
03 May 2023
Reporting date
03 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

US FDA APPROVES GSKS RSV VACCINE FOR OLDER ADULTS

Filing date
03 May 2023
Reporting date
03 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TOTAL VOTING RIGHTS

Filing date
02 May 2023
Reporting date
02 May 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
28 Apr 2023
Reporting date
28 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

GSK RSV OA VACCINE GAINS POSITIVE EMA CHMP OPINION

Filing date
27 Apr 2023
Reporting date
27 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

1ST QUARTER RESULTS

Filing date
26 Apr 2023
Reporting date
26 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

EMA VALIDATES JEMPERLI FILING FOR NEW INDICATION

Filing date
25 Apr 2023
Reporting date
25 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
20 Apr 2023
Reporting date
20 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
19 Apr 2023
Reporting date
19 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

GSK REACHES AGREEMENT TO ACQUIRE BELLUS HEALTH INC

Filing date
18 Apr 2023
Reporting date
18 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

DIRECTOR/PDMR SHAREHOLDING

Filing date
17 Apr 2023
Reporting date
17 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

GEPOTIDACIN POSITIVE PHASE III DATA

Filing date
17 Apr 2023
Reporting date
17 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

TOTAL VOTING RIGHTS

Filing date
03 Apr 2023
Reporting date
03 Apr 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
6-K File 001-15170

POSITIVE PHASE III RUBY RESULTS FOR JEMPERLI

Filing date
28 Mar 2023
Reporting date
28 Mar 2023
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .